Company profile

CorrGene company profile

CorrGene is an innovative company focusing on the research and development and production of new anti-cancer drugs and rare diseases with gene editing technology and cell therapy. The company was established by a group of cell and gene therapy experts, virologists, oncologists, hematologists and biopharmaceutical industry veterans. CorrGene was established in January, 2022 in Jiangsu, China.

Business identity

Operating status
Active
Company type
For Profit
Founded
2022-01-01

Headquarters

Headquarters
Ning’er, Yunnan, China
Country code
CN
Continent
Asia

Capital profile

Funding and company signals

Funding stage
Seed
Funding rounds
1
Total equity funding
$15.7M
Last funding
Seed / $15.7M / 2022-02-28
Last equity funding
Seed / $15.7M
Investors
3

Founders and investors

Investors

Golden Capital PartnersMed-Fine CapitalWuxi Capital

People at this company

Preview only. Contact details are available after you sign in.

Log in to view people and contact details at this company

Contact information and company affiliations may no longer be accurate. Verify details before reaching out.

Shipment data

Explore detailed shipment data

Sign in to view shipment history, products, suppliers, and trade lanes for this company.

Log in to view shipment data

Shipment records and coverage can change as the dataset is updated.